nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines
|
Damjanovska, Sofi |
|
|
39 |
5 |
p. 786-789 |
artikel |
2 |
Can a combination of vaccination, probiotic and organic acid treatment in layer hens protect against early life exposure to Salmonella Typhimurium and challenge at sexual maturity?
|
Groves, Peter J. |
|
|
39 |
5 |
p. 815-824 |
artikel |
3 |
Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore
|
Zhong, Youjia |
|
|
39 |
5 |
p. 780-785 |
artikel |
4 |
Combine two different dengue vaccines could efficiently target dengue-naive subjects. Comment to Macias A, Ruiz-Palacios G, Ramos-Castaneda J. Combine dengue vaccines to optimize effectiveness. Vaccine. 2020 Jun 26;38(31):4801–4804
|
Guy, Bruno |
|
|
39 |
5 |
p. 779 |
artikel |
5 |
Constructing an ethical framework for priority allocation of pandemic vaccines
|
Fielding, J |
|
|
39 |
5 |
p. 797-804 |
artikel |
6 |
Coping with COVID
|
Berman, Len |
|
|
39 |
5 |
p. 777-778 |
artikel |
7 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
5 |
p. IFC |
artikel |
8 |
Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study
|
Jiang, Xuewen |
|
|
39 |
5 |
p. 846-852 |
artikel |
9 |
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018
|
Su, John R. |
|
|
39 |
5 |
p. 839-845 |
artikel |
10 |
Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 & 18): Regulatory toxicology studies in mice, rats and rabbits – An innovative approach
|
Srinivasa Reddy, Y. |
|
|
39 |
5 |
p. 853-863 |
artikel |
11 |
Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers
|
Godinot, Léo Donzel |
|
|
39 |
5 |
p. 805-814 |
artikel |
12 |
Regulatory Harmonization and Streamlining of Clinical Trial Applications globally should lead to faster clinical development and earlier access to life-saving vaccines
|
Scheppler, Lorenz |
|
|
39 |
5 |
p. 790-796 |
artikel |
13 |
Timing of COVID-19 vaccine approval and endorsement by public figures
|
Bokemper, Scott E. |
|
|
39 |
5 |
p. 825-829 |
artikel |
14 |
Vaccination rate and adherence of tick-borne encephalitis vaccination in Germany
|
Schley, Katharina |
|
|
39 |
5 |
p. 830-838 |
artikel |